Drs. Jared Weiss, Assistant Professor, Clinical Research Hematology/Oncology, University of North Carolina School of Medicine, and Josh Bauml, Assistant Professor of Medicine, Hospital of the University of Pennsylvania, join GRACE to discuss updates relating to pembrolizumab, nivolumab and PD-L1 markers for head and neck cancers.
Head and Neck Cancer
If you have been NEWLY DIAGNOSED START HERE
VIDEOS
Buddy Scalera is a podcaster and Senior Director of Content Strategy in Global Health Science at the Medicines Company, and has been a member of the...
In this thirteenth video, the fifth from the afternoon breakout survivorship sessions, GRACE presents Exercise for Lung Cancer Patients, with Jeffrey Eagan DPT.
In this twelfth video from the Targeted Therapy in Lung Cancer Live Patient Forum Webcast series, GRACE presents the afternoon breakout sessions. The fourth video from these sessions is Dealing with Down Days, presented by Jeanice Hansen, MSW, LCSW, OSW-C.
In this eleventh video from the Targeted Therapies in Lung Cancer Patient Forum, the third from the afternoon breakout survivorship sessions, GRACE presents Chemo Brain, with Denise Damek, MD.
ARTICLES
From the Grace Archives | Originally Published March 10, 2011 | By Dr Ramchandran Hospice is both an organization and a philosophy of care. It was...
From the Grace Archives | Originally published August 12, 2012 | By Dr West I’m on call for my oncology group this weekend, and I’ve had the situation...
From the Grace Archives | Originally Published May 27, 2011 | By Dr West This week, a “Sounding Board” article by Drs. Thomas Smith and Bruce Hillner...
From the Grace Archives | Originally Published July 30, 2011 | By Dr West Our weekly thoracic tumor board, a multidisciplinary meeting with multiple...
From the GRACE Archives -- Originally Published November 5, 2009 | By Dr. Weiss I treat cancer for two and only two reasons. I want my patients to...